Press Releases

Month Year

Month Year

Dec 16, 2021

Evofem Biosciences and Orion Biotechnology Launch Collaboration to Develop MPT Product Candidate to Include HIV Prevention
Dec 9, 2021

Evofem Biosciences Expects Record High Phexxi Prescriptions and Strong Net Revenue Growth in Fourth Quarter 2021
Dec 8, 2021

Evofem Biosciences to Adjourn Special Meeting of Stockholders on December 8, 2021

-- Meeting to Reconvene on December 15, 2021 --
Nov 30, 2021

Evofem Biosciences Announces Successful Type C Meeting with FDA for STI Prevention Product Candidate
Nov 22, 2021

Evofem Biosciences Successfully Extends Cumulative Net Sales Covenant Timing to June 30, 2023

Show per page